Introduction
In recent years we have been interested in the linkage of dehydroamino acid derivatives to benzo [b] thiophenes and in the study of the fluorescence and antimicrobial activity of the resulting products. Using Suzuki coupling we were able to synthesize either β-benzo [b] thienyl or β, β-bis(benzo [b] thienyl)dehydroamino acid derivatives. [1, 2] The latter were cyclized to the corresponding dehydroprolines using a metal-assisted intramolecular cyclization and the fluorescence properties of one of them were studied.
[2b]
Here we describe the application of the one pot borylation Suzuki coupling (BSC) to the synthesis of new benzo [b] thienyldehydrophenylalanine derivatives from methylated or methoxylated benzo [b] thiophenes and brominated dehydrophenylalanines. This method was first applied by Baudoin et al. [3] to the synthesis of 2,2'-disubstituted biaryl compounds. Substituted halobenzenes were submitted to borylation using pinacolborane, followed by in situ Suzuki cross-coupling with a second 2-substituted halobenzene. The authors postulated that the borylation should be performed on the component bearing an ortho-EDG and the other coupling component having an ortho-EWG. The method is also based on the use of the electron-rich sterically hindered 2-(dicyclohexylphosphino)biphenyl as ligand. [4] Recently we applied this reaction to the synthesis of 2-methyl-2'-nitrobiaryl compounds in the benzo [b] thiophene series to obtain thienocarbazoles. [5] More recently another application of the BSC to the synthesis of substituted biaryl compounds appeared, using DPEphos as ligand and CsF as base in the Suzuki coupling. [6] In this work the brominated Suzuki coupling component is not aromatic and this constitutes a novel application of the BSC reaction as reported by us previously. [7] The C-N metal-assisted cyclization [2] of differently ortho-methylated Z-β-benzo[b] thienyldehydrophenylalanine derivatives was studied. A thienoindole thus obtained showed to be fluorescent. Preliminary antimicrobial studies were performed either on the precursors or on the cyclized products. [1]
Results and Discussion

Synthesis
The bromobenzo [b] thiophenes were borylated with pinacolborane followed by Suzuki coupling with (Z)-1 or (E)-1 in a one pot procedure (Scheme In all cases debrominated benzo [b] thiophenes were isolated as by-products (25-50%). When the two components were aromatic the component to be borylated needs an EDG and the other Suzuki coupling component requires an EWG. [3, 5] In our case however the carbamate group of the dehydroamino acid derivative has a slight electron donating effect and this can affect the product yields which were moderate to good ( Table 1 ). The products maintained the stereochemistry of the starting materials as observed by NOE difference experiments.
Enhancements on the phenyl protons for the E isomers and on the ortho-methyl or methoxy and on the benzo[b]thienyl protons for the Z isomers were observed irradiating the αNH as shown as examples in Fig. 1 and 2 for compounds (Z)-3 and (E)-3. In Fig.1 we observe an enhancement of In order to obtain cyclic amino acids, compound (Z)-2 and (Z)-3 were submitted to our cyclization conditions [2] (Scheme 2 and 3). Compound (Z)-2 gave two cyclized products resulting either from isomerization followed by cyclization giving indole 5 (major product), or from direct cyclization giving thienoindole 6. The reaction was also performed at 100 o C for 6h but the same compounds were obtained in similar amounts. and antifungal using Candida albicans as a representative of fungi was assessed for compounds (Z)-2, (Z)-3, 5, 6, 7 and 8. The minimal inhibitory concentration (MIC in µg/mL) was determined ( Table 2 ) using an adaptation of agar streak dilution method based on radial diffusion. [8] In the same conditions different concentrated solutions of Ampicillin (antibacterial) and Cyclohexamide (antifungal) were used as standards. The MIC was considered to be the lowest concentration of the tested compound which inhibits growth of bacteria or fungi on the plate. The diameters of the inhibition zones corresponding to the MICs are presented in Table 2 .
The compounds tested are not active against Pseudomonas aeruginosa starting from DMSO solutions of 6000 µg/mL of each compound. Compounds ( 
Fluorescence studies
The fluorescence of compounds 5 and 6 was studied (Fig 3) . Thienoindole 6 showed a λ em = standard method [9] with 9,10-diphenylanthracene in EtOH (2x10 -5 M) as reference (Φ EtOH = 0.95) [10] using λ exc = 333 nm. Indole 5 showed a λ em = 408 nm and a relative quantum yield of fluorescence in dichloromethane Φ dcm = 0.0067 using the same method and λ exc = 296 nm. The excitation wavelengths (λ exc ) were chosen from the UV spectra of the compounds (see experimental). From the results obtained it can be concluded that thienoindole 6 can be used as a fluorescent probe. Wavelength ( From preliminary antimicrobial studies on the precursors and on the cyclized products it is possible to conclude that all the compounds were active against the Gram positive bacteria (B.
cereus and B. subtilis), the cyclized products being more active (lower MICs). The latter were also active against E. coli despite presenting very different MICs and in turn the precursors were the only compounds active against Candida albicans. Fluorescence studies on compounds 5 and 6 show that the thienoindole 6 can be used as a fluorescent probe.
Experimental Section
General Remarks: Melting points were determined on a Gallenkamp apparatus and are uncorrected. The 1 H NMR spectra were measured on a Varian Unity Plus at 300 MHz. Spin-spin decoupling techniques were used to assign the signals. NOE difference experiments were performed to determine the stereochemistry of the products.
The 13 C NMR spectra were measured in the same instrument at 75.4 MHz (using DEPT θ 45º). The UV spectra were recorded on a Schimadzu UV-250 1PC, UV-vis recording spectrophotometer.
Elemental analyses were determined on a LECO CHNS 932 elemental analyser. Mass spectra (EI) and HRMS were made by the mass spectrometry service of University of Vigo-Spain.
Column chromatography was performed on Macherey-Nagel silica gel 230-400 mesh. Petroleum ether refers to the boiling range 40-60 o C. Ether refers to diethyl ether. When solvent gradient was used the increase of polarity was done gradually from neat petroleum ether to mixtures of ether/petroleum ether increasing 10% of ether until the isolation of the product.
For the in vitro antimicrobial activity, suspensions of the microorganism were prepared to contain approximately 10 8 cfu/mL and the plates were inoculated. A stock solution of the synthesized compound (6000 µg/mL) in DMSO was prepared and graded dilutions (10x) of the tested compounds were incorporated in a cavity (depth 3mm, diameter 4mm) made in the center of the petridish (nutrient agar for antibacterial activity and sabouraud dextrose agar medium for antifungal activity). The plates were incubated at 37 o C (for bacteria) and at 30 o C (for fungi) for 24h in duplicate. Positive control using only inoculation and negative control using only DMSO in the cavity were carried out.
The fluorescence studies were performed on a spectrofluorimeter Spex Fluorolog 1680 Double Spectrometer.
Samples quantum yields are given by
where A is the absorbance at the excitation wavelength, F the integrated emission area and n the refraction index of the solvents used. Subscripts refer to the reference (r) or sample (s) compound.
Compounds (Z)-1 and (E)-1 were already described by us.
[1] The 6-bromotrimethylbenzo[b]thiophenes were prepared according to a procedure described by others [11a] and previously used by us.
[11b] thiophene [12] (3.00 mmol, 0.500 g) in dry ether (30 mL) protected against light it was added 1 equiv. of Br 2 (3.00 mmol, 0.154 mL) and a small amount of Fe. The reaction was followed by 1 H-NMR and it was left stirring for 1h. Iced water (10mL) was added and the mixture was stirring for 10 min. The phases were separated and the aqueous phase was extracted with more ether (2x30 mL). The organic phases were collected, washed with a 5% solution of sodium sulfite and a 10% solution of sodium carbonate and dried (MgSO 4 ). Removal of the solvent gave a solid that was submitted to column chromatography using a petroleum ether. and pinacolborane (3 equiv.) were added, and the mixture was left with rapid stirring at 80 ºC for 1h. After cooling, a pure stereoisomer of β-bromodehydrophenylalanine derivative (1 equiv.) and Ba(OH) 2 .8H 2 O (3 equiv.) were added, and the mixture was heated at 100 ºC for 1h 30 min. Water and ethyl acetate were added, the phases were separated, and then the aqueous phase was extracted with more ethyl acetate. The organic phases were collected, dried (MgSO 4 ), filtered and then the solvent was evaporated at reduced pressure to give a brown solid, that was subjected to column chromatography.
Boc-(Z)-∆Phe[β-(2,3,5-trimethylbenzo[b]thien-6-yl)]-OMe (Z)-2:
The procedure described above was followed using compound 6-bromo-2,3,5-trimethylbenzo[b]thiophene (0.500 mmol, 128 mg) and Boc-(Z)-∆Phe(β-Br)-OMe (0.410 mmol, 147 mg), but adding water (200 µL) in the second step. Column chromatography using solvent gradient from neat petroleum ether to 30% diethyl ether/petroleum ether, gave product (Z)-2 (112 mg, 61%) as an oil. Crystallization from diethyl ether/n-hexane gave light-yellow solid, mp 154-156 ºC. 1 
Boc-(E)-∆Phe[β-(2,3,5-trimethylbenzo[b]thien-6-yl)]-OMe (E)-2:
The procedure described above was followed using compound 6-bromo-2,3,5-trimethylbenzo[b] H 6.47, N 3.10, S 7.10; found C 68.90, H 6.54 , N 3.14, S 7.03.
Boc-(Z)-∆Phe[β-(2,3,7-trimethylbenzo[b]thien-6-yl)]-OMe (Z)-3:
The procedure described above was followed using compound 6-bromo-2,3,7-trimethylbenzo[b] thiophene (0.500 mmol, 128 mg) and Boc-(Z)-∆Phe(β-Br)-OMe (0.500 mmol, 178 mg), but adding water (200 µL) in the second step. Column chromatography using solvent gradient from neat petroleum ether to 30% diethyl ether/petroleum ether, gave product (Z)-3 (122 mg, 52%) as an oil. Crystallization from petroleum ether gave white crystals, mp 149-150 ºC. calcd. C 69. 12, H 6.47, N 3.10, S 7.10; found C 69.15, H 6.63, N 3.11, S 6 .91.
Boc-(E)-∆Phe[β-(2,3,7-trimethylbenzo[b]thien-6-yl)]-OMe (E)-3:
The procedure described above was followed using compound 6-bromo-2,3,7-trimethylbenzo[b]thiophene (0.310 mmol, 79.0 mg) and Boc-(E)-∆Phe(β-Br)-OMe (0.310 mmol, 111 mg), but adding water (125 µL) in the second step. Column chromatography using solvent gradient from neat petroleum ether to 30% diethyl ether/petroleum ether, gave product (E)-3 (41 mg, 43%) as an oil.
Crystallization from petroleum ether gave light-yellow crystals, mp 172-173 ºC. H 6.47, N 3.10, S 7.10; found C 69.19, H 6.60 , N 3.14, S 7.11.
Boc-(Z)-∆Phe[β-(2,3-dimethyl-6-methoxybenzo[b]thien-7-yl)]-OMe (Z)-4:
The procedure described above was followed using compound 7-bromo-2,3-dimethyl-6-methoxybenzo[b]thiophene (0.400 mmol, 108 mg) and Boc-(Z)-∆Phe(β-Br)-OMe (0.400 mmol, 142 mg), but adding water (160 µL) in the second step. Column chromatography using solvent gradient from neat petroleum ether to 40% diethyl ether/petroleum ether, gave product (Z)-4 (100 mg, 54%) as an yellow solid. Recrystallization from petroleum ether gave yellow crystals, mp 104-106 ºC. 1 H 6.25, N 3.00, S 6.86; found C 66.93, H 6.62, N 2.96, S 6.63 .
Boc-(E)-∆Phe[β-(2,3-dimethyl-6-methoxybenzo[b]thien-7-yl)]-OMe (E)-4:
The procedure described above was followed using compound 7-bromo-2,3-dimethyl-6-methoxybenzo[b] thiophene (0.340 mmol, 92.0 mg) and Boc-(E)-∆Phe(β-Br)-OMe (0.340 mmol, 119 mg), but adding water (134 µL) in the second step. Column chromatography using solvent gradient from neat petroleum ether to 40% diethyl ether/petroleum ether, gave H 6.25, N 3.00, S 6.86; found C 66.54, H 6.33, N 3.07, S 6.91 . Methyl N-(tert-butoxycarbonyl)-3-(2,3,7-trimethylbenzo[b]thien-6-yl)indole-2-carboxylate (7): The procedure described above was applied using compound (Z)-3 (0.310 mmol, 140 mg) and heating for 2h at 100ºC. Column chromatography using solvent gradient from neat petroleum ether to 10% diethyl ether / petroleum ether, gave compound (70.0 mg, 50%) as an oil. 
General
